Three biotech stocks to buy now

Professional investor Daniel Koller picks three cutting edge three biotech stocks to buy now.

A professional investor tells us where he'd put his money. This week: Daniel Koller of BB Biotech selects three biotech plays.

Investors have a vast array of markets and sectors to choose from, but biotechnology is one of the most fascinating and promising. The market has expanded by 560% in a decade and is expected to grow by around 10% a year over the next ten years. And an investment in biotechnology isn't just an opportunity to profit personally: you are also helping to fund cutting-edge science and bring forward the discovery of cures or treatments that have so far eluded the medical establishment.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Dr Daniel Koller is head of BB Biotech at Bellevue Asset Management and resides in Zurich, Switzerland. He occasionally writes for MoneyWeek online and print and gives his share tips.